Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysiss
Article in Heliyon (April 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
First-line pemetrexed and carboplatin plus anlotinib for epidermal growth factor receptor wild-type and anaplastic lymphoma kinase-negative lung adenocarcinoma with brain metastasis
Article in Medicine (September 2020)
AGRP and ESPL1 as Biomarkers of Brain-Metastasis in Lung Adenocarcinoma
Article in Journal of Physics Conference Series (August 2019)